On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Statistical Genetics of Complex Diseases
-
1. Population genetics considerations
- Prof. Nan Laird
-
2. Gene-by-environment interaction: study designs and analytical methods
- Prof. L. Adrienne Cupples
-
3. Analysis of SNP haplotypes
- Prof. Lyle Palmer
-
4. Statistical issues in epidemiological studies of gene-environment interaction
- Dr. Peter Kraft
- Prof. Donna Spiegelman
- Molecular Epidemiology of Pulmonary Diseases
-
5. Molecular epidemiology of lung cancer
- Prof. David Christiani
- Autoimmune Diffuse Connective Tissue Diseases
-
7. Environmental scleroderma: the evidence for putative triggers
- Prof. Maureen Mayes
- Drug-Induced Disease
-
8. Drug-induced lupus
- Prof. Evelyn Hess
- Archived Lectures *These may not cover the latest advances in the field
-
9. Biomarkers of exposure
- Prof. Thomas Smith
-
10. GIS and spatial statistics
- Prof. Louise Ryan
-
11. Gene-by-environment interactions in COPD
- Prof. Edwin Silverman
-
14. Indians, twins and scleroderma: genetic and genomic studies
- Prof. Frank Arnett
-
15. Gene by environment interaction in asthma
- Prof. Scott Weiss
-
16. Molecular epidemiology of lung cancer
- Prof. David Christiani
-
18. Infectious environmental factors and systemic lupus erythematosus
- Prof. Judith James
Printable Handouts
Navigable Slide Index
- Introduction
- University hospital
- Potential immunologic agents
- Drugs implicated with autoimmune syndromes
- Lab features with drug related Lupus
- Minocycline Lupus syndrome
- Chlorpromazine induces apoptosis
- Drug Lupus with sulphasalazine
- Statin drugs
- Disorders associated with antiphospholipid Ab.
- Biologics with Lupus profiles
- Patients on entanercept
- I.V. anti TNF alpha with low dose MTX
- Autoantibody testing
- Anti-nuclear/anti-smooth-muscle antibodies
- Drug/toxin eosinophilic myositis
- Drugs associated with vasculitis
- Examples of ethnopharmacology
- N-acetyltransferase (NAT2)
- Acetylator effects on metabolic fate of drugs
- Thoughts about "drug toxicity" phenotypes
- Fate of environmental factors
- Proposed guidelines for EARDs
- Stage 1,2 and 3
- Refining the proposed guidelines for EARDs
Topics Covered
- The occurrence of drug and environment-related lupus and lupus-like syndromes
- The medications that have been reported in association with autoimmune symptoms and syndromes
- The major associations and cause(s) of these commonly noted clinical syndromes
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Hess, E. (2007, October 1). Drug-induced lupus [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2025, from https://doi.org/10.69645/GPAA4478.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Evelyn Hess has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.